Search Count: 64
All
Selected
![]() |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2026-02-18 Classification: VIRAL PROTEIN Ligands: A1CZV, EDO, NA |
![]() |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2026-02-18 Classification: VIRAL PROTEIN Ligands: ZN, A1CZW |
![]() |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.39 Å Release Date: 2026-01-21 Classification: VIRAL PROTEIN Ligands: A1CLE, ZN |
![]() |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2026-01-21 Classification: VIRAL PROTEIN Ligands: ZN, A1CLF |
![]() |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2026-01-21 Classification: VIRAL PROTEIN Ligands: ZN, A1CLD, PO4, K |
![]() |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2026-01-21 Classification: VIRAL PROTEIN Ligands: ZN, EDO, A1CLN, NA |
![]() |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2026-01-21 Classification: VIRAL PROTEIN Ligands: ZN, A1CLP, GOL |
![]() |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2026-01-21 Classification: VIRAL PROTEIN Ligands: ZN, A1CLO, EDO |
![]() |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2026-01-21 Classification: VIRAL PROTEIN Ligands: ZN, EDO, A1CLL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2025-12-24 Classification: IMMUNE SYSTEM |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2025-12-24 Classification: IMMUNE SYSTEM |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2025-12-24 Classification: IMMUNE SYSTEM |
![]() |
Crystal Strcture Of Adenosylcobinamide Kinase/Adenosylcobinamide Phosphate Guanylyltransferase Cobu From Akkermansia Muciniphila, Crystal Form I
Organism: Akkermansia muciniphila atcc baa-835
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2025-10-08 Classification: TRANSFERASE Ligands: MLA |
![]() |
Crystal Strcture Of Adenosylcobinamide Kinase/Adenosylcobinamide Phosphate Guanylyltransferase Cobu From Akkermansia Muciniphila, Crystal Form Ii
Organism: Akkermansia muciniphila atcc baa-835
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2025-10-08 Classification: TRANSFERASE Ligands: GOL |
![]() |
Crystal Strcture Of Adenosylcobinamide Kinase/Adenosylcobinamide Phosphate Guanylyltransferase Cobu From Akkermansia Muciniphila In Complex With Adocbi-Gdp
Organism: Akkermansia muciniphila atcc baa-835
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2025-10-08 Classification: TRANSFERASE Ligands: A1ER6, GOL |
![]() |
Crystal Strcture Of Adenosylcobinamide Kinase/Adenosylcobinamide Phosphate Guanylyltransferase Cobu H49A From Akkermansia Muciniphila In Complex With Gtp
Organism: Akkermansia muciniphila atcc baa-835
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2025-10-08 Classification: TRANSFERASE Ligands: GTP, MG, 3PO |
![]() |
Organism: Human immunodeficiency virus 1
Method: ELECTRON MICROSCOPY Release Date: 2025-10-01 Classification: VIRAL PROTEIN Ligands: NAG |
![]() |
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-10-01 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-10-01 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-10-01 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |




















